Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
Picture_1

Global Press Conference on Discovering Changjiang Civilization Through Culture, Ecology and Transportation Was Successfully Held in Hefei, East China’s Anhui Province

HEFEI, China--(BUSINESS WIRE)--The Global Press Conference on Discovering Changjiang Civilization Through Culture, Ecology and Transportation was successfully held at the...

Hangzhou-QihanLOGO

Qihan Biotech announces the completion of pre-Series B financing for developing stem cell-derived cell therapy products with high-throughput multiplexable genome editing

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable...

kldiscovery_cenza2023

KLDiscovery Inc. Announces Agreement to Acquire Cenza Technologies Private Limited to Establish Global Delivery Center in India

The acquisition will strengthen KLDiscovery’s Managed Document Review and enhance the Company’s contract lifecycle management offering. EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--#KLD--KLDiscovery...

Seagen_Logo_RGB

PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

news_6

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial